Diagnostic screening programs help catch cancer, abnormalities or other diseases before they reach an advanced stage, saving lives and healthcare costs. Screening programs include, lung, breast, prostate, and cervical cancer, among many others.
Ultrasound is routinely used to screen for HCC. However, its utility is limited by numerous factors, including patient body habitus, operator experience and certain liver conditions, all of which contribute to decreases in sensitivity.
In conjunction with prevention efforts, the introduction of screening examinations has resulted in a reduction of nearly 6 million cancer-related deaths since 1975.
Breast density is most often discussed within the context of cancer risk, but new research suggests that it also could be used as a marker of cardiometabolic health.
The newly cleared offering, AutoChamber, was designed with opportunistic screening in mind. It can evaluate many different kinds of CT images, including those originally gathered to screen patients for lung cancer.
Computed radiography systems, often in combination with PACS, are bringing cost reductions in film, FTEs, file room space and repeat studies, and driving efficiency and exam turnaround time in imaging centers.
The American Healthcare Radiology Administrators (AHRA) this week announced that Roland Rhynus, CRA, FAHRA will receive the AHRA Gold Award at the organization's 32nd annual meeting and exposition, August 1-5, in Boston.
Oncology information technology system provider IMPAC Medical Systems Inc. said this week that the DICOM-RT Treatment Machine interface (DTMI) standard will be used at the Proton Therapy Center at The University of Texas M.D. Anderson Cancer to connect IM
Cardinal Health Inc. this week inked an agreement with Radiology Support Devices (RSD) making it the exclusive worldwide distributor for RSD products through its Radiation Management Services business.
RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.
Deepak Bhatt, MD, director of the Mount Sinai Fuster Heart Hospital and principal investigator of the TRANSFORM trial, explains an emerging technique for cardiac screening: combining coronary CT angiography with artificial intelligence for plaque analysis to create an approach similar to mammography.
A total of 16 cardiology practices from 12 states settled with the DOJ to resolve allegations they overbilled Medicare for imaging agents used to diagnose cardiovascular disease.
